Helius Medical Technologies, Inc. (OTC:HSDT)
Industry: Services

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, or acquiring noninvasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a medical device in Canada for the treatment of chronic balance deficit associated with a mild to moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. Helius Medical Technologies, Inc. is headquartered in Newtown, Pennsylvania.

Current Quote*
Last: $2.060
Change: 0.059
Book: $4.361
Volume: 12,938

As Of: 08/16 13:07 ET
*Quotes delayed by 20min.

Graphs for HSDT

3 Month Graph

6 Month Graph

1 Year Graph